Cargando…
M10. SERUM AND CLINICAL MARKERS ASSOCIATED WITH MEMBRANE PUFA CONTENT IN A POPULATION OF STABILISED AND TREATED SCHIZOPHRENIA OUTPATIENTS
BACKGROUND: Various candidate biomarkers have been proposed in schizophrenia to better characterise the several forms of the disorder. Among these candidates, peripheral (e.g. immunological, inflammatory, microbial) and brain (structural and functional) factors have been suggested and could help sub...
Autores principales: | Bosc, Nicolas, Adrien, Vladimir, Ferreri, Florian, Mouchabac, Stephane, Fumat, Hugo, Lamaziere, Antonin, Tareste, David, Tessier, Cedric, Nuss, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234087/ http://dx.doi.org/10.1093/schbul/sbaa030.322 |
Ejemplares similares
-
Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid
por: Adrien, Vladimir, et al.
Publicado: (2023) -
T202. THE EFFECT OF ANTIPSYCHOTIC DRUGS ON MEMBRANE FUSION: AN IN VITRO STUDY
por: Adrien, Vladimir, et al.
Publicado: (2020) -
M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE RCT
por: Yagoda, Sergey, et al.
Publicado: (2020) -
Impact of the COVID-19 pandemic on outpatient postpartum care utilization
por: El Helou, Nicole, et al.
Publicado: (2022) -
Timing of COVID-19 and Development of Hypertensive Disorders in Pregnancy
por: Bank, Tracy Caroline, et al.
Publicado: (2022)